FdaApplication
NDA 021842
Identifiers
- fda_app_no: NDA021842
Properties
| Property | Value |
|---|---|
| applicant_name | TAKEDA PHARMACEUTICALS USA INC |
| application_type | NDA |
| approval_date | 2005-08-29 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ACTOPLUS MET | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE | 850MG;EQ 15MG BASE | TABLET;ORAL |
| ACTOPLUS MET | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE | 500MG;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
2 products